CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-05 | Brennan Aoife Director | Grant or award | +3,914 | 3,914 | ||
| 2020-08-05 | Brennan Aoife Director | Grant or award · Stock Option (Right to Buy) | +6,496 | 6,496 | ||
| 2020-08-05 | Brennan Aoife Director | Grant or award · Stock Option (Right to Buy) | +10,400 | 10,400 | ||
| 2020-07-24 | Yu K Peony Chief Medical Officer | Sale | −3,351 | $42.35 | $142K | 205,576 |
| 2020-06-22 | Wettig Thane Chief Commercial Officer | Grant or award | +30,000 | 30,600 | ||
| 2020-06-22 | Wettig Thane Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2020-06-16 | Cotroneo Pat SVP, Finance and CFO | Sale | −3,928 | $39.68 | $156K | 271,060 |
| 2020-06-11 | Conterno Enrique A Chief Executive Officer | Purchase | +19,800 | $35.28 | $699K | 27,800 |
| 2020-06-10 | Conterno Enrique A Chief Executive Officer | Purchase | +8,000 | $36.29 | $290K | 8,000 |
| 2020-06-09 | Rosenkranz Roberto Pedro Director | Exercise or conversion | +12,000 | $28.65 | $344K | 84,100 |
| 2020-06-09 | Rosenkranz Roberto Pedro Director | Exercise or conversion | +12,000 | $19.05 | $229K | 96,100 |
| 2020-06-09 | Rosenkranz Roberto Pedro Director | Exercise or conversion · Stock Option (Right to Buy) | −12,000 | 0 | ||
| 2020-06-09 | Rosenkranz Roberto Pedro Director | Exercise or conversion · Stock Option (Right to Buy) | −12,000 | 0 | ||
| 2020-06-08 | Chung Christine SVP, China Operations | Shares withheld for taxes | −3,038 | $33.61 | $102K | 156,653 |
| 2020-06-08 | Cotroneo Pat SVP, Finance and CFO | Shares withheld for taxes | −2,156 | $33.61 | $72K | 274,988 |
| 2020-06-08 | Yu K Peony Chief Medical Officer | Shares withheld for taxes | −3,292 | $33.61 | $111K | 208,927 |
| 2020-06-08 | Kouchakji Elias SVP, Clinical Dev, Drug Safety | Shares withheld for taxes | −2,728 | $33.61 | $92K | 130,141 |
| 2020-06-04 | Schoeneck James A Director | Grant or award | +4,700 | 9,400 | ||
| 2020-06-04 | Schoeneck James A Director | Grant or award · Stock Option (Right to Buy) | +7,800 | 7,800 | ||
| 2020-06-04 | Rosenkranz Roberto Pedro Director | Grant or award | +4,700 | 72,100 |
Page 20 of 33 · 651 trades